COVID-19News

HMD to supply 265 million AD Syringes for covid vaccination 

The company has also received orders for 240 million KOJAK syringes for COVAX via UNICEF and 79 million for Brazil for Dispovan syringes

Hindustan Syringes & Medical Devices (HMD) has received an order from the Indian government to supply 265 million AD Syringes till September this year. Over 440 million KOJAK syringes will be supplied for India’s massive vaccination drive by September including 177 million by April this year alongside supplies of Dispovan to the private hospitals and vaccination clinics.

“This is in addition to our ongoing global commitments to support global vaccination projects for 0.1ml and 0.5 ml AD Kojak syringes in developing world whether for Yellow Fever or Measles or Hepatitis B or Pentavalent or BCG etc. This is in addition to Covid vaccination requirements of 0.3ml for Pfizer’s vaccines or 0.5 ml AD Kojak for Astra Zeneca/ Serums or Bharat Biotech’s vaccines. We have also received orders for 240 million KOJAK syringes for COVAX via UNICEF and 79 million for Brazil for Dispovan syringes via PAHO which we are executing alongside,” said Rajiv Nath, MD, HMD.

“India is our priority and comes first but we do have to honour our global commitments and play a balancing role. So, for now, we are allocating 2/3 capacity of KOJAK to GoI & 1/3 to our regular global UN clients. We are happy to complement vaccines diplomacy with syringes diplomacy and raise the brand India flag in over 120 countries worldwide,” added Nath.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close